HDAC9 and neoplasm: Several in vitro and in vivo preclinical studies have suggested that valproic acid significantly inhibits cancer cell proliferation and metastasis by modulating multiple signaling pathways, tumor immune response, and cell cycle arrest through HDAC inhibition [11, 37].